Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
Mothers with postpartum depression ‘highly vulnerable’ during pandemic
Rates and severity of postpartum depression and anxiety symptoms among women who sought treatment for postpartum depression worsened during the COVID-19 pandemic.
Governments, opioid companies reach $26B agreement
State and local governments across the U.S. have reached an agreement with Johnson & Johnson, McKesson, Cardinal Health and AmerisourceBergen that will provide up to $26 billion to fight the opioid epidemic, the parties involved announced.
Log in or Sign up for Free to view tailored content for your specialty!
In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA
In a meta-analysis of omega-3 fatty acid trials, eicosapentaenoic acid monotherapy yielded the greatest reduction in CV risk vs. a combination of eicosapentaenoic acid and docosahexaenoic acid.
Pimavanserin lowers relapse risk in patients with dementia-related psychosis
In a phase 3 trial of pimavanserin that came to a premature halt for efficacy, patients with dementia-related psychosis who continued the treatment had a lower risk for relapse than those who were switched to placebo, researchers reported.
FDA requests removal of strongest warning against statin use among pregnant women
The FDA requested removal of its contraindication against using cholesterol-lowering statin medicines among pregnant patients; however, most patients should stop statins once they learn they are pregnant.
Apixaban linked to fewer adverse events in older adults with frailty, atrial fibrillation
Among older adults with atrial fibrillation, apixaban was linked to lower rates of adverse events across all frailty levels compared with warfarin, a retrospective observational study showed.
Regional, ethnic disparities may exist with empagliflozin efficacy in HF
The effects of the SGLT2 inhibitor empagliflozin varied depending on region and racial/ethnic group, with the most benefit observed in those with the highest ratios of HF hospitalization to CV death, according to EMPEROR-Reduced trial data.
Intervention fails but still ‘provides a roadmap’ to reduce antimicrobial use, experts say
An intervention researchers hoped would improve infection management did not significantly reduce antimicrobial use among nursing home residents with dementia, data showed.
Pravastatin fails to reduce preeclampsia in high-risk pregnancies
Pravastatin compared with placebo did not reduce incidence of delivery with preeclampsia among pregnant women at high risk, according to findings published in Circulation.
20% of older patients prescribed gabapentin after surgery use it long term
One-fifth of older patients discharged with gabapentin following a surgical procedure had the prescription refilled for more than 90 days, suggesting long-term use is common, according to an analysis of Medicare data.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read